Efficacy, safety, and tolerability of the rotigotine transdermal patch in patients with early-stage, idiopathic Parkinson's disease: A multicenter, multinational, randomized, double-blind, placebo-controlled trial

被引：0
|
作者：
Watts, RL
Wendt, J
Nausieda, PL
Boroojerdi, B
Poole, KH
Sommerville, KW
机构：
来源：
MOVEMENT DISORDERS | 2004年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P737
引用
收藏
页码：S258 / S258
页数：1
相关论文
共 50 条
  • [1] Efficacy of the rotigotine transdermal patch in patients with early-stage, idiopathic Parkinson's disease. Results of a multicenter, multinational, randomized, double-blind, placebo-controlled trial
    Watts, R. L.
    Wendt, J.
    Nausieda, P. L.
    Boroojerdi, B.
    Poole, K. H.
    Sommerville, K. W.
    EUROPEAN JOURNAL OF NEUROLOGY, 2004, 11 : 9 - 10
  • [2] Efficacy and safety of rotigotine transdermal patch in Chinese patients with early-stage Parkinson's disease: A randomized, double-blind, placebo-controlled study
    Zhang, Z.
    Asgharnejad, M.
    Du, X.
    Surmann, E.
    Bauer, L.
    MOVEMENT DISORDERS, 2015, 30 : S137 - S138
  • [3] Transdermal Rotigotine in Early Stage Parkinson's Disease: A Randomized, Double-blind, Placebo-controlled Trial
    Mizuno, Yoshikuni
    Nomoto, Masahiro
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    MOVEMENT DISORDERS, 2013, 28 (10) : 1447 - 1450
  • [4] Transdermal rotigotine in advanced Parkinson's disease: a randomized, double-blind, placebo-controlled trial
    Nomoto, Masahiro
    Mizuno, Yoshikuni
    Kondo, Tomoyoshi
    Hasegawa, Kazuko
    Murata, Miho
    Takeuchi, Masahiro
    Ikeda, Junji
    Tomida, Takayuki
    Hattori, Nobutaka
    JOURNAL OF NEUROLOGY, 2014, 261 (10) : 1887 - 1893
  • [5] Transdermal rotigotine in advanced Parkinson’s disease: a randomized, double-blind, placebo-controlled trial
    Masahiro Nomoto
    Yoshikuni Mizuno
    Tomoyoshi Kondo
    Kazuko Hasegawa
    Miho Murata
    Masahiro Takeuchi
    Junji Ikeda
    Takayuki Tomida
    Nobutaka Hattori
    Journal of Neurology, 2014, 261 : 1887 - 1893
  • [6] Rotigotine transdermal patch in Chinese patients with early Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
    Zhang, Zhen-Xin
    Shang, Hui-Fang
    Hu, Xingyue
    Chen, Shengdi
    Zhao, Zhongxin
    Du, Xinlu
    Surmann, Erwin
    Bauer, Lars
    Asgharnejad, Mahnaz
    PARKINSONISM & RELATED DISORDERS, 2016, 28 : 49 - 55
  • [7] Transdermal rotigotine - Double-blind, placebo-controlled trial in Parkinson disease
    Jankovic, Joseph
    Watts, Ray L.
    Martin, Wayne
    Boroojerdi, Babak
    ARCHIVES OF NEUROLOGY, 2007, 64 (05) : 676 - 682
  • [8] Rotigotine transdermal patch (Neupro®) is efficacious and safe in patients with early-stage, idiopathic Parkinson's disease, regardless of gender, age, duration and severity of disease.: Results of a multicenter, randomized, double-blind, placebo-controlled trial
    Watts, RL
    LeWitt, PA
    Sommerville, KW
    Boroojerdi, B
    MOVEMENT DISORDERS, 2005, 20 : S93 - S93
  • [9] Safety, tolerability, and efficacy of continuous transdermal dopaminergic stimulation with rotigotine patch in early-stage idiopathic Parkinson disease
    Güldenpfennig, WM
    Poole, KH
    Sommerville, KW
    Boroojerdi, B
    CLINICAL NEUROPHARMACOLOGY, 2005, 28 (03) : 106 - 110
  • [10] Rotigotine transdermal patch in Chinese patients with advanced Parkinson's disease: A randomized, double-blind, placebo-controlled pivotal study
    Zhang, Zhen-Xin
    Liu, Chun-Feng
    Tao, En-Xiang
    Shao, Ming
    Liu, Yi-Ming
    Wang, Jian
    Asgharnejad, Mahnaz
    Xue, Hai-Bo
    Surmann, Erwin
    Bauer, Lars
    PARKINSONISM & RELATED DISORDERS, 2017, 44 : 6 - 12
12345